Heron Therapeutics
HRTX
#10088
Rank
NZ$0.12 B
Marketcap
NZ$0.66
Share price
26.48%
Change (1 day)
-66.66%
Change (1 year)

EPS for Heron Therapeutics (HRTX)

EPS in 2023 (TTM): NZ-$1.94

According to Heron Therapeutics's latest financial reports the company's current EPS (TTM) is NZ-$0.34. In 2022 the company made an earnings per share (EPS) of NZ-$3.07 an increase over its 2021 EPS that were of NZ-$3.99.

EPS history for Heron Therapeutics from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)NZ-$1.94-36.68%
2022NZ-$3.07-23.11%
2021NZ-$3.99-10%
2020NZ-$4.44-0%
2019NZ-$4.441.21%
2018NZ-$4.38-32.7%
2017NZ-$6.51-19.34%
2016NZ-$8.0754.76%
2015NZ-$5.221.73%
2014NZ-$5.13-16.23%
2013NZ-$6.1291.67%
2012NZ-$3.19-31.45%
2011NZ-$4.66-27.06%
2010NZ-$6.39-43.75%
2009NZ-$11.36-57.33%
2008NZ-$26.62-82.92%
2007NZ-$155.8020.61%
2006NZ-$129.18175.76%
2005NZ-$46.84-21.43%
2004NZ-$59.62100%
2003NZ-$29.81-38.24%
2002NZ-$48.26161.54%
2001NZ-$18.45-106.46%
2000NZ$285.492051.55%
1999NZ$13.27839.73%
1998NZ$1.41-105.48%
1997NZ-$25.79-88.16%
1996NZ-$217.80

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
SurModics
SRDX
NZ-$2.18 547.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Pacira Biosciences
PCRX
NZ$0.62-284.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
NZ$17.76-5,368.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
NZ$0.71-310.53%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Nektar Therapeutics
NKTR
NZ-$5.25 1,457.89%๐Ÿ‡บ๐Ÿ‡ธ USA